Skip to main content
Premium Trial:

Request an Annual Quote

Cplant, Virtual Cell


Sandia National Laboratories, based in Albuquerque, NM, has released its Cplant cluster software to the public.

Cplant enables users to modularly assemble off-the-shelf desktop computer components into a supercomputer. The software is modeled after the system software that Sandia developed for the ASCI Red supercomputer built by Intel.

Developer Neil Pundit said the open-source release will allow researchers free access to a scalable, Linux-based, off-the-shelf computer, while improvements made by new users will be communicated back to Sandia.

Release 1.0 of the software can be downloaded from the Cplant website at cplant and totals approximately 43 MB. Users must agree to software licensing terms before downloading.

The National Resource for Cell Analysis and Modeling, located at the Center for Biomedical Imaging Technology at the University of Connecticut Health Center, has released a beta version of Virtual Cell 3.0, a computational framework for modeling cell biological processes.

New features include a complete redesign of the software architecture and interface, enhanced usability, integration of the data export feature, and enhanced performance through the client side cache.

Virtual Cell is available at

Guildford, UK-based ID Business Solutions has released ActivityBase 5.0, a suite of products for chemical and biological data management.

New ActivityBase 5.0 modules include StructureBase for chemical compound registration; ReactionBase for storing, managing, and searching reactions and reaction schemes; Natural Products to manage the process of finding and isolating an active compound from a natural organism; and the SARgen suite of products to query ActivityBase for biological and chemical information.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more